immune-checkpoint

Documents about immune-checkpoint

• Trial of Therapeutic Cancer Vaccine OSE2101 in Patients With Non-Small Cell Lung Cancer and Secondary Resistance to Immune Checkpoint Inhibitor#180192ClinicalTrials.gov
• Immune Checkpoint Inhibition With Lurbinectedin Relapsed/Recurrent SCLC#184838ClinicalTrials.gov
• Association between the Prognostic Nutritional Index and survival outcomes in hepatocellular carcinoma patients receiving immune checkpoint inhibitors: a systematic review and meta-analysis.#368060NCBI PubMed Central
• Analyzing Clinical Outcomes and Genomic Data of American Indian Patient Population#373587ClinicalTrials.gov
• Expression of IL4 Induced Gene 1 in Patients With Cutaneous Melanoma: Value in Prognosis and/or in Predictive Response to Immune Checkpoint Inhibitors#451408ClinicalTrials.gov
• A Comparative Study of the Treatment of Real-world Patients With Clear Cell Carcinoma of the Ovary#828891ClinicalTrials.gov
• Evaluation of Blood TMB for the Efficacy of Atezolizumab [BUDDY]#851739ClinicalTrials.gov
• Adebrelimab Plus Chemoradiotherapy Followed by Adebrelimab Maintenance in Limited-Stage SCLC#879807ClinicalTrials.gov
• PD-1 Inhibitor Based Induction Chemotherapy Followed by De-escalation Protocols in OPSCC#1031752ClinicalTrials.gov
• A Prospective Real World Evidence Study (PROWES) for Concordance Rate of Blood-based 3D Genome Conformation Mapping (Episwitch CiRT®) to Identify Likelihood of Response and Actual Response Rates to PD-(L)-1 Checkpoint Inhibitors Across Multiple Oncological Indications.#143556ClinicalTrials.gov
• A Study of Lorigerlimab With Docetaxel or Docetaxel Alone in Participants With Metastatic Castration-Resistant Prostate Cancer#896424ClinicalTrials.gov
• Evaluating the Efficacy of Hyperthermic Intraperitoneal Treatment to Enhance the Sensitivity of Immune Checkpoint Inhibitor in Patients With Advanced Ovarian Cancer： A Single-arm Study#146466ClinicalTrials.gov
• The mechano-immunological landscape in the tumor microenvironment: From mechanical sensing to a new therapeutic paradigm#307852Europe PMC
• PET Quantitative Assessments of Solid Tumor Response to Immune Checkpoint Blockade Therapy#356479ClinicalTrials.gov
• The clinical value of adding immune checkpoint inhibitors to radiotherapy for cancer: a systematic review and meta-analysis#464131Figshare
• TACE in Combination With PD-1/PD-L1 Inhibitors and Molecular Target Therapies for Intermediate HCC#868195ClinicalTrials.gov
• Baseline Lymphopenia Predicts Survival in ICI-Naïve Solid Tumor Patients Receiving Immune Checkpoint Inhibitors: A Propensity-Matched Real-World Pan-Cancer Analysis#465418ODU Digital Commons
• The Associations of Psychological Stress With Therapy Efficacy and Prognosis of Lung Cancer (STRESS-LUNG)#174856ClinicalTrials.gov
• Prognostic value of von Willebrand factor levels in patients with metastatic melanoma treated by immune checkpoint inhibitors#178205HAL (France)
• Tigit And Gdf-15 As Biomarkers And Targets In Renal Cell Carcinoma Resistant To Immune Checkpoint Inhibitors#260915EliScholar
• The rechallenge benefit score: A clinical decision tool for patients progressing after immunotherapy#280409HAL (France)
• Traditional Chinese medicine as a potential barrier-oriented sensitization strategy for immune checkpoint blockade in microsatellite-stable colorectal cancer: from resistance mechanisms to translational validation.#368196NCBI PubMed Central
• The effect of immune checkpoint inhibitor combination therapies in metastatic renal cell carcinoma patients with and without previous cytoreductive nephrectomy: A systematic review and meta-analysis#388095HAL (France)
• Early Tumor Shrinkage and Clinical Outcomes for Esophageal Squamous Cell Carcinoma Patients Treated with Immune Checkpoint Inhibitors: Real-World Observational Study#439915Springer Nature OA
• A Clinical Study on the Analysis of Risk Factors for the Occurrence of PD-1/PD-L1 Inhibitor-associated Liver Injury in Lung Cancer Patients#444886ClinicalTrials.gov
• Durable Response to Nivolumab Combined With Metformin in Advanced Pancreatic Cancer: A Case Report With Seven Years of Follow-Up#465446OKAYAMA UNIVERSITY SCIENTIFIC ACHIEVEMENT REPOSITORY
• Radiofrequency Ablation Plus Systematic Neoadjuvant Therapy for Recurrent Hepatocellular Carcinoma (RANT Study)#801440ClinicalTrials.gov
• AI-Guided First-Line Immunotherapy Selection in Unresectable Hepatocellular Carcinoma#852431ClinicalTrials.gov
• Exploratory Study on the Efficacy and Safety of Nebulized hUC-MSC-Derived Exosomes for Non-Acute CIP#864493ClinicalTrials.gov
• Study of Chemoradiotherapy With Envafolimab For The Treatment of Locally Advanced Cervical Cancer#881968ClinicalTrials.gov
• Naltrexone and Propranolol Combined With Immunotherapy#892860ClinicalTrials.gov
• Efficacy and Safety of HGXJT in Bone Metastatic NSCLC Patients#896478ClinicalTrials.gov
• Disitamab Vedotin Plus Lenvatinib and PD-1 Inhibitors for Treating HER2-positive Advanced Biliary Tract Cancer#897228ClinicalTrials.gov
• Evaluation of Denosumab in Combination With Immune Checkpoint Inhibitors in Patients With Unresectable or Metastatic Melanoma#913896ClinicalTrials.gov
• Intestinal Low-Dose Radiotherapy Plus Immunochemotherapy for Conversion of Borderline Resectable/Unresectable Esophageal Squamous Cell Carcinoma#125850ClinicalTrials.gov
• FT500 as Monotherapy and in Combination With Immune Checkpoint Inhibitors in Subjects With Advanced Solid Tumors#148776ClinicalTrials.gov
• HTS-Oracle X: AI-Guided Prospective Discovery of Small Molecule Immune Checkpoint Binders#363822Figshare
• Inflammation‐Driven Lymphoid Structures: Organization, Function, and Clinical Impact Across Autoimmunity, Cancer, and Checkpoint Toxicity#471879HAL (France)
• CD4+ T Cells Sensitize Quasimesenchymal Breast Tumors Lacking CD73 to Anti-CTLA4 Immune Checkpoint Blockade Therapy#485300Europe PMC
• Immunotherapy for Recurrent Cervical Cancer Refractory to Platinum-based Chemotherapy: Multi-Center Trial#628521ClinicalTrials.gov
• Impact of a Prebiotic Food-enriched Diet (PreFED) in Combination With Ipilimumab/Nivolumab Combination Immune Checkpoint Blockade (ICB) in ICB-refractory Melanoma Patients#845134ClinicalTrials.gov
• Adebrelimab Combined With Neoadjuvant Chemotherapy in Borderline Resectable Locally Advanced Esophageal Squamous Cell Carcinoma#851472ClinicalTrials.gov
• Sitravatinib and Tislelizumab in Patients With Metastatic Uveal Melanoma With Liver Metastases.#979394ClinicalTrials.gov
• Dietary Intervention for NSCLC Patients Treated With ICI#1030857ClinicalTrials.gov
• Study to Evaluate the Safety, Tolerability, and Pharmacodynamics of Investigational Treatments in Combination With Standard of Care Immune Checkpoint Inhibitors in Participants With Advanced Melanoma#1047412ClinicalTrials.gov
• Stoking an anti-liver cancer immune response with cryoablation plus an intratumoral TLR9 agonist and dual checkpoint inhibitors#1053160Europe PMC
• Health-related quality of life with adjuvant immune checkpoint inhibition in renal cell carcinoma: A qualitative study of UK participants in the phase III RAMPART trial.#1053925NCBI PubMed Central
• Immune checkpoint inhibition in metastatic or non-resectable melanoma after failure of adjuvant anti-PD-1 treatment. A EUMelaReg real-world evidence study#14287HAL (France)
• PD-1 blockade does not enhance alloimmunization after allogeneic dendritic cell vaccination in cancer patients#172988HAL (France)
• Clinical utility of diagnosing Lynch syndrome in gynecologic oncology: a joint statement from four Japanese academic societies#477041OKAYAMA UNIVERSITY SCIENTIFIC ACHIEVEMENT REPOSITORY